Authors: Idell, S Mazar, AP Bitterman, P Mohla, S Harabin, AL

Citation: S. Idell et al., Fibrin turnover in lung inflammation and neoplasia, AM J R CRIT, 163(2), 2001, pp. 578-584

Authors: Mazar, AP

Citation: Ap. Mazar, The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer, ANTI-CANC D, 12(5), 2001, pp. 387-400

Authors: Al-Atrash, G Kitson, RP Xue, YM Mazar, AP Kim, MH Goldfarb, RH

Citation: G. Al-atrash et al., uPA and uPAR contribute to NK cell invasion through the extracellular matrix, ANTICANC R, 21(3B), 2001, pp. 1697-1704

Authors: Tarui, T Mazar, AP Cines, DB Takada, Y

Citation: T. Tarui et al., Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction, J BIOL CHEM, 276(6), 2001, pp. 3983-3990

Authors: Guo, YJ Higazi, AA Arakelian, A Sachais, BS Cines, D Goldfarb, RH Jones, TR Kwaan, H Mazar, AP Rabbani, SA

Citation: Yj. Guo et al., A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo, FASEB J, 14(10), 2000, pp. 1400-1410

Authors: Mishima, K Mazar, AP Gown, A Skelly, M Ji, XD Wang, XD Jones, TR Cavenee, WK Huang, HJS

Citation: K. Mishima et al., A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin, P NAS US, 97(15), 2000, pp. 8484-8489